| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |